Cytokinetics | CYTK - SCHULD





SCHULD Veränderung Datum
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
Amgen USD 57.32B 2.72B 2026-03
Arca Biopharma USD 0 0 2025-03
Bayer EUR 36.45B 2.93B 2025-12
Biogen USD 8.09B 1.53B 2026-06
Brainstorm Cell Therapeutics USD 1.2M 1.2M 2025-03
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Capricor Therapeutics USD 3.38M 0 2025-03
Cytokinetics USD 1.29B 4.48M 2026-03
Eisai JPY 186.08B 50.58B 2026-03
Eli Lilly USD 43.37B 867M 2026-03
Exelixis USD 165.93M 3.61M 2026-06
Geron USD 122.07M 74K 2026-03
Halozyme Therapeutics USD 2.14B 2.01M 2026-03
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
Ligand Pharmaceuticals USD 451.98M 486K 2026-03
Merck USD 49.12B 222M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Pfizer USD 63.19B 536M 2026-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06